Pseudomonas aeruginosa is increasingly resistant to conventional antibiotics, which can be compounded by the formation of biofilms on surfaces conferring additional resistance. P. aeruginosa was grown in sub-inhibitory concentrations of the antimicrobial peptides (AMPs) melimine and Mel4 or ciprofloxacin for 30 consecutive days to induce the development of resistance. Antibiofilm effect of AMPs and ciprofloxacin was evaluated using crystal violet and live/dead staining with confocal microscopy. Effect on the cell membrane of biofilm cells was evaluated using DiSC(3)-5 dye and release of intracellular ATP and DNA/RNA. The minimum inhibitory concentration (MIC) of ciprofloxacin increased 64-fold after 30 passages, but did not increase for mel...
The formation of surface-attached cellular agglomerates, the so-called biofilms, contributes signifi...
Pseudomonas aeruginosa has gained increasing significance as opportunistic pathogens in hospitalised...
Abstract With the increasing recognition of biofilms in human disease, the development of novel anti...
Pseudomonas aeruginosa is increasingly resistant to conventional antibiotics, which can be compounde...
Pseudomonas aeruginosa is increasingly resistant to conventional antibiotics, which can be compounde...
Pseudomonas aeruginosa is increasingly resistant to conventional antibiotics, which can be compounde...
Pseudomonas aeruginosa is increasingly resistant to conventional antibiotics, which can be compounde...
Staphylococcus aureus can develop resistance by mutation, transfection or biofilm formation. Resista...
Staphylococcus aureus can develop resistance by mutation, transfection or biofilm formation. Resista...
Staphylococcus aureus can develop resistance by mutation, transfection or biofilm formation. Resista...
Staphylococcus aureus can develop resistance by mutation, transfection or biofilm formation. Resista...
Staphylococcus aureus can develop resistance by mutation, transfection or biofilm formation. Resista...
Staphylococcus aureus can develop resistance by mutation, transfection or biofilm formation. Resista...
Biofilms are resistant to antibiotics and are a major source of persistent and recurring infections ...
Microbes are known to colonize surfaces and form biofilms. These biofilms are communities of microbe...
The formation of surface-attached cellular agglomerates, the so-called biofilms, contributes signifi...
Pseudomonas aeruginosa has gained increasing significance as opportunistic pathogens in hospitalised...
Abstract With the increasing recognition of biofilms in human disease, the development of novel anti...
Pseudomonas aeruginosa is increasingly resistant to conventional antibiotics, which can be compounde...
Pseudomonas aeruginosa is increasingly resistant to conventional antibiotics, which can be compounde...
Pseudomonas aeruginosa is increasingly resistant to conventional antibiotics, which can be compounde...
Pseudomonas aeruginosa is increasingly resistant to conventional antibiotics, which can be compounde...
Staphylococcus aureus can develop resistance by mutation, transfection or biofilm formation. Resista...
Staphylococcus aureus can develop resistance by mutation, transfection or biofilm formation. Resista...
Staphylococcus aureus can develop resistance by mutation, transfection or biofilm formation. Resista...
Staphylococcus aureus can develop resistance by mutation, transfection or biofilm formation. Resista...
Staphylococcus aureus can develop resistance by mutation, transfection or biofilm formation. Resista...
Staphylococcus aureus can develop resistance by mutation, transfection or biofilm formation. Resista...
Biofilms are resistant to antibiotics and are a major source of persistent and recurring infections ...
Microbes are known to colonize surfaces and form biofilms. These biofilms are communities of microbe...
The formation of surface-attached cellular agglomerates, the so-called biofilms, contributes signifi...
Pseudomonas aeruginosa has gained increasing significance as opportunistic pathogens in hospitalised...
Abstract With the increasing recognition of biofilms in human disease, the development of novel anti...